DK1465663T3 - Brugsfærdige paracetamol-injektionsoplösninger som indeholder propylenglycol som det eneste CO-oplösningsmiddel - Google Patents

Brugsfærdige paracetamol-injektionsoplösninger som indeholder propylenglycol som det eneste CO-oplösningsmiddel

Info

Publication number
DK1465663T3
DK1465663T3 DK02779486T DK02779486T DK1465663T3 DK 1465663 T3 DK1465663 T3 DK 1465663T3 DK 02779486 T DK02779486 T DK 02779486T DK 02779486 T DK02779486 T DK 02779486T DK 1465663 T3 DK1465663 T3 DK 1465663T3
Authority
DK
Denmark
Prior art keywords
ready
propylene glycol
solvent
solutions containing
injection solutions
Prior art date
Application number
DK02779486T
Other languages
Danish (da)
English (en)
Inventor
Thao Nguyen-Xuan
Original Assignee
Bioren S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioren S A filed Critical Bioren S A
Application granted granted Critical
Publication of DK1465663T3 publication Critical patent/DK1465663T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK02779486T 2001-10-16 2002-10-15 Brugsfærdige paracetamol-injektionsoplösninger som indeholder propylenglycol som det eneste CO-oplösningsmiddel DK1465663T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI002135A ITMI20012135A1 (it) 2001-10-16 2001-10-16 Soluzioni iniettabili pronte all'uso di paracetamolo
PCT/EP2002/011498 WO2003033026A1 (en) 2001-10-16 2002-10-15 Ready-to-use paracetamol injection solutions containing propylene glycol as the only cosolvent

Publications (1)

Publication Number Publication Date
DK1465663T3 true DK1465663T3 (da) 2008-05-13

Family

ID=11448506

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02779486T DK1465663T3 (da) 2001-10-16 2002-10-15 Brugsfærdige paracetamol-injektionsoplösninger som indeholder propylenglycol som det eneste CO-oplösningsmiddel

Country Status (15)

Country Link
US (1) US8178121B2 (it)
EP (1) EP1465663B1 (it)
JP (1) JP4543679B2 (it)
CN (1) CN1274293C (it)
AT (1) ATE382369T1 (it)
AU (1) AU2002342826B2 (it)
CA (1) CA2463681C (it)
DE (1) DE60224449T2 (it)
DK (1) DK1465663T3 (it)
ES (1) ES2301685T3 (it)
IL (2) IL161390A0 (it)
IT (1) ITMI20012135A1 (it)
NZ (1) NZ532936A (it)
PT (1) PT1465663E (it)
WO (1) WO2003033026A1 (it)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2851164B1 (fr) 2003-02-14 2005-04-22 Xuan Tho Nguyen Formulation liquide injectable de paracetamol
FR2862872A1 (fr) * 2003-12-02 2005-06-03 Palbian Snc Composition a l'etat aqueux pour l'application perfusable d'un principe actif, notamment pharmacologique tel que le paracetamol.
US9585849B2 (en) * 2006-04-17 2017-03-07 The Burlington Hc Research Group, Inc. Broad spectrum antiviral and methods of use
US20090239817A1 (en) * 2006-04-17 2009-09-24 Goverment Of The United States Of America, As Represented By The Secretary, Dept Of Health Organic thiophosphate antiretroviral agents
AU2006346318B2 (en) * 2006-07-18 2011-02-10 Genfarma Laboratorio S.L. Injectable liquid paracetamol formulation
EP1992334A1 (en) * 2007-05-08 2008-11-19 Docpharma NV/SA Storage-stable formulation of oxidation-sensitive phenolic drug, especially paracetamol, comprises aqueous drug solution deoxygenated by a temperature-controlled manufacturing process of the formulation
EP2198019A4 (en) * 2007-08-30 2011-05-11 Iogen Energy Corp PROCESS FOR PRODUCING CELLULASE
ES2321906B1 (es) * 2008-11-28 2010-02-09 Laboratorios Normon, S.A. Composicion farmaceutica que comprende una solucion acuosa de paracetamol.
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
EP2377516B1 (en) 2010-04-14 2012-06-20 B. Braun Melsungen AG Acetaminophen composition
ES2414557B1 (es) * 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
US20140303254A1 (en) * 2013-04-08 2014-10-09 InnoPharma Licensing LLC Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
BR102014005885B1 (pt) 2014-03-13 2021-04-13 Biotec Biológica Indústria Farmacêutica Ltda E.P.P Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
EA028075B1 (ru) * 2014-04-29 2017-10-31 Мыкола Ивановыч ГУМЕНЮК Фармацевтическая композиция
WO2016097899A1 (en) 2014-12-20 2016-06-23 Troikaa Pharmaceuticals Limited Injectable formulations of paracetamol

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195918B (en) 1984-03-14 1988-08-29 Jerome Corbiere Process for producing pharmaceutical compositions containing non-steroide antiflogistic active components
KR930011994B1 (ko) * 1991-08-16 1993-12-23 대광제약 주식회사 파라세타몰의 생체이용율을 높이는 방법 및 이 생체이용율이 높아진 파라세타몰을 함유한 제제
JP3430320B2 (ja) 1994-03-14 2003-07-28 あづま姿株式会社 衣紋掛
JP3913795B2 (ja) * 1995-09-28 2007-05-09 エスエス製薬株式会社 安定な解熱鎮痛剤配合液剤
JPH09286724A (ja) * 1996-04-19 1997-11-04 Takeda Chem Ind Ltd 経口用安定液剤
FR2751875B1 (fr) 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
US5766622A (en) 1996-08-14 1998-06-16 The Procter & Gamble Company Inhibiting undesirable taste in oral compositions
IT1301976B1 (it) 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
US6006659A (en) * 1998-10-13 1999-12-28 Rosenthal; Richard A. Personal pasteurization system
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
DE10112325A1 (de) 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols

Also Published As

Publication number Publication date
CN1274293C (zh) 2006-09-13
IL161390A0 (en) 2004-09-27
EP1465663B1 (en) 2008-01-02
PT1465663E (pt) 2008-04-10
US8178121B2 (en) 2012-05-15
WO2003033026A1 (en) 2003-04-24
US20040247627A1 (en) 2004-12-09
ITMI20012135A1 (it) 2003-04-16
DE60224449T2 (de) 2009-04-02
IL161390A (en) 2009-06-15
NZ532936A (en) 2007-04-27
JP4543679B2 (ja) 2010-09-15
CA2463681A1 (en) 2003-04-24
ATE382369T1 (de) 2008-01-15
EP1465663A1 (en) 2004-10-13
CA2463681C (en) 2011-03-15
ES2301685T3 (es) 2008-07-01
JP2005505609A (ja) 2005-02-24
CN1571678A (zh) 2005-01-26
AU2002342826B2 (en) 2006-09-07
DE60224449D1 (de) 2008-02-14

Similar Documents

Publication Publication Date Title
DK1465663T3 (da) Brugsfærdige paracetamol-injektionsoplösninger som indeholder propylenglycol som det eneste CO-oplösningsmiddel
BRPI0006823B8 (pt) composição farmacêutica estabilizada, preparação de injeção, e kit comercial
DE60322513D1 (de) Stabilisierte TNFR-Fc Formulierung mit Arginin
BRPI0416986A (pt) preparação farmacêutica compreendendo um anticorpo contra o receptor de egf
PT1200426E (pt) Tieno-3-il-sulfonilamino (tio) carbonil-triazolino (ti) onas substituidas
DE69725825D1 (de) 5-HT1F-Agonisten
BR0009951A (pt) Composição de higiene pessoal
MA27748A1 (fr) Formulation liquide injectable de paracetamol
EP1273299A4 (en) MINOXIDIL PREPARATIONS
NO20054787D0 (no) Indenderivater som farmasotiske midler
DE502005008631D1 (de) Dermatologischen zubereitungen
DE602005016659D1 (de) Wässrige zusammensetzung mit einem thiazol-derivat
DE50209545D1 (de) Flüssigkristallines medium
EA200600753A1 (ru) Скважинная жидкость, содержащая вязкоупругие поверхностно-активные гели с пониженной концентрацией соли
BR0001201A (pt) Composto ( poli ) tia-alcinóicos, composição cosmética, utilização de uma composição cosmética, utilização de um composto e composição farmacêutica
ATE420918T1 (de) Sauerstoffbarriereformulierungen
ATE295352T1 (de) Phenanthridine-n-oxide mit pde-iv hemmender wirkung
SE9903290D0 (sv) Novel compounds
NO20024664L (no) Sammensetning basert pÕ sulfid av sjeldent jordmetall med forbedret kjemisk stabilitet, fremgangsmÕte for fremstilling deravog anvendelse derav som pigment
BR0115996A (pt) Sulfamidotienopirimidinas
TR200101493T2 (tr) Eletriptan hidrobromid monohidrat
DE60017374D1 (de) Antibakterielle mittel
ATE305474T1 (de) Triphendioxazin-verbindungen
DE60203890D1 (de) Apfelsäureadditionssalze von terbinafin
DE60026292D1 (de) Eine stabilisierte isothiazolon-zusammensetzung und ein verfahren zur stabilisierung von isothiazolon